Back to Search Start Over

A Guide to Management of Sleepiness in ESKD.

Authors :
So JY
Warburton KM
Rosen IM
Source :
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2020 May; Vol. 75 (5), pp. 782-792. Date of Electronic Publication: 2020 Jan 23.
Publication Year :
2020

Abstract

Daytime sleepiness, also known as hypersomnolence, is common among patients receiving maintenance dialysis and following successful kidney transplantation. Sleepiness may be secondary to medical comorbid conditions, medication side effect, insufficient sleep syndrome, and sleep-disordered breathing or the result of a primary central disorder of hypersomnolence, such as narcolepsy. Unrecognized and untreated sleep disorders are associated with substantial morbidity and mortality among patients with end-stage kidney disease. Effective management of hypersomnolence can improve quality of life in patients with kidney disease. This review focuses on the principal causes of sleepiness in patients with end-stage kidney disease. Awareness of these disorders by treating nephrologists is crucial. This review provides a systematic approach to guide providers through the recognition, early diagnosis, and treatment of hypersomnolence, which is commonly encountered in this patient population. Areas of future research are also suggested.<br /> (Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1523-6838
Volume :
75
Issue :
5
Database :
MEDLINE
Journal :
American journal of kidney diseases : the official journal of the National Kidney Foundation
Publication Type :
Academic Journal
Accession number :
31983503
Full Text :
https://doi.org/10.1053/j.ajkd.2019.09.010